Epstein Secrets

): PE.Interp(Rfx IFE).5; Lyme Ab/Western Blot Reflex Iron and TIBC; Testosterone,Pree+weakly Bound; Prolactin; OHM-Sulfate; Homocystle)ine. Plasma; C-Reactive Protein, Cardiac: Hemoglobin Ale: Prostate-Specific Ag. Serum TSH; Vitamin D, 25-Hydroxy; Uric Acid, Serum; GOT; Insulin; Ambiguous Test Order; Ferritin, S

tes: <7.0 Prostate-Specific Ag, Serum Prostate Specific Ag, Serum Roche ECLIA methodology. 0.8 ng/mL 4.8 - 5.6 02 0.0 - 4.0 02 According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA

less than 3.1 ng/ml, is considered to represent clinical deficiency. FSH and LH LH 3.7 mIU/mL 1.7 - 8.6 01 FSH 4.4 miU/mL 1.5 - 12.4 01 C-Reactive Protein, Cardiac 1.56 mg/L 0.00 - 3.00 01 Relative Risk for Future Cardiovascular Event Low <1.00 Average 1.00 - 3.00 High >3.00 Hemoglobin Ale

ults with diabetes: <7.0 Prostate-Specific Ag, Serum Prostate Specific Ag, Serum 0.7 ng/mL 0.0 - 4.0 01 Roche ECLIA methodology. According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA

e, Direct, S; DHEA-Sulfate; Cortisol; TSH; Rheumatoid Arthritis Factor; Prostate -Specific Ag, Serum; IGF-1; Vitamin D, 25-Hydroxy; Panel 083935; C-Reactive Protein, Cardiac; HCV Ab w/Rflx to Verification; ANA w/Reflex; Homocyst(e)ine, Plasma; Uric Acid, Serum; LDH; GGT; Magnesium, Serum; Zinc, Plasma or serum;

ITS REFERENCE INTERVAL LAB Prostate-Specific Ag, Serum Prostate Specific Ag, Serum Roche ECLIA methodology. 0.6 ng/mL 0.0 - 4.0 According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA

und Will Follow V 9.0 - 46.0 02 Testosc., F+W Bound Will Follow ng/dL 40.0 - 250.0 Vitamin B12 and Folate Will Follow FSH and LH LH FSH C-Reactive Protein, Cardiac 3.7 mIU/mL 1.7 - 8.6 01 4.4 mIU/mL 1.5 - 12.4 01 1.56 mg/L 0.00 - 3.00 01 Relative Risk for Future Cardiovascular Event Low <

257-S80-2371D Date collected:09/14/2018 1255 Local TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB TSH Roche ECLIA methodology. According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA